IP Library › Granted Patent US 12,569,689
Granted Patent B2
US 12,569,689 · App. 18/338,341 · Granted Mar 10, 2026

Medical device and method for detecting atrioventricular block

Inventors: Michelle M. Galarneau (Minneapolis, MN); Vincent P. Ganion (Blaine, MN); Saul E. Greenhut (Denver, CO); Yanina Grinberg (Plymouth, MN); Todd J. Sheldon (North Oaks, MN); Paul R. Solheim (Blaine, MN); Hyun J. Yoon (Vadnais Heights, MN)
Assignee: Medtronic, Inc.
A61N1/36578A61N1/025A61N1/36507A61N1/36535A61N1/36542A61N1/36585A61N1/37211G16H20/30G16H40/67
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,689
App. No.
18/338,341
Filed
Jun 20, 2023
Granted
Mar 10, 2026
Kind
B2
Art Unit
3796
USPC
607/18
Abstract

A medical device includes a motion sensor configured to sense a motion signal. The medical device includes a control circuit configured to determine at least one ventricular event metric from the motion signal sensed over multiple of atrial cycles, determine that the ventricular event metric meets atrioventricular block criteria and generate an output in response to determining the atrioventricular block.

Claims (68)

1 . A medical device comprising:

a motion sensor configured to sense a motion signal;

a control circuit configured to:

for each atrial cycle of a plurality of atrial cycles:

determine a fiducial point of the motion signal;

determine an atrioventricular activation time from an atrial event to the fiducial point of the motion signal;

determine a ventricular event metric based on the atrioventricular activation times determined for the plurality of atrial cycles;

determine that the ventricular event metric meets output criteria; and

generate an output comprising a pacing therapy adjustment in response to determining that the ventricular event metric meets the output criteria;

a memory configured to store the generated output; and

a therapy delivery circuit configured to deliver a pacing therapy according to the pacing therapy adjustment.

2 . The medical device of claim 1 wherein the control circuit is further configured to determine the ventricular event metric by determining a trend of the atrioventricular activation time based on the atrioventricular activation times.

3 . The medical device of claim 1 wherein the control circuit is further configured to determine the ventricular event metric based on the atrioventricular activation times by determining a variability of the atrioventricular activation times.

4 . The medical device of claim 1 wherein the control circuit is further configured to:

compare the atrioventricular activation times to a first threshold activation time;

count each atrioventricular activation time that is greater than the first threshold activation time as an atrioventricular block cycle; and

determine the ventricular event metric as the count of the atrioventricular block cycles.

5 . The medical device of claim 4 wherein the control circuit is further configured to:

compare the atrioventricular activation times to a second threshold activation time that is less than the first threshold activation time; and

count each atrioventricular activation time that is less than the second threshold activation time as an atrioventricular block cycle.

6 . The medical device of claim 1 wherein the control circuit is further configured to:

determine the ventricular activity metric by:

determining a representative value of the atrioventricular activation times;

determining a range of the atrioventricular activation times; and

determine that the ventricular activity metric meets the output criteria when the representative value is greater than a threshold atrioventricular activation time and the range is greater than a threshold range.

7 . The medical device of claim 1 wherein the control circuit is further configured to determine the ventricular activity metric by determining a sum of differences between successive atrioventricular activation times of the determined atrioventricular activation times.

8 . The medical device of claim 1 wherein the control circuit is further configured to determine the fiducial point of the motion signal as a maximum peak amplitude of the motion signal sensed during the respective atrial cycle.

9 . The medical device of claim 1 wherein the control circuit is further configured to:

detect a condition for monitoring for atrioventricular block; and

determine the ventricular activation times in response to detecting the condition for monitoring for atrioventricular block.

10 . The medical device of claim 1 further comprising:

a sensing circuit configured to sense a cardiac electrical signal; and

a telemetry circuit;

wherein the control circuit is further configured to store an episode of at least one of the cardiac electrical signal and the motion signal in response to determining that the ventricular event metric meets the atrioventricular block criteria; and

the telemetry circuit is configured to transmit the stored episode.

11 . A method comprising:

sensing a motion signal;

for each atrial cycle of a plurality of atrial cycles:

determining a fiducial point of the motion signal;

determining an atrioventricular activation time from an atrial event to the fiducial point of the motion signal;

determining a ventricular event metric based on the atrioventricular activation times determined for the plurality of atrial cycles;

determining that the ventricular event metric meets output criteria;

generating an output comprising a pacing therapy adjustment in response to determining that the ventricular event metric meets the output criteria;

storing the generated output in a memory; and

delivering a pacing therapy according to the pacing therapy adjustment.

12 . The method of claim 11 further comprising determining the ventricular event metric by determining a trend of the atrioventricular activation time based on the atrioventricular activation times.

13 . The method of claim 11 further comprising determining the ventricular event metric based on the atrioventricular activation times by determining a variability of the atrioventricular activation times.

14 . The method of claim 11 further comprising:

comparing the atrioventricular activation times to a first threshold activation time;

counting each atrioventricular activation time that is greater than the first threshold activation time as an atrioventricular block cycle; and

determining the ventricular event metric as the count of the atrioventricular block cycles.

15 . The method of claim 14 further comprising:

comparing the atrioventricular activation times to a second threshold activation time that is less than the first threshold activation time; and

counting each atrioventricular activation time that is less than the second threshold activation time as an atrioventricular block cycle.

16 . The method of claim 11 further comprising:

determining the ventricular activity metric by:

determining a representative value of the atrioventricular activation times;

determining a range of the atrioventricular activation times; and

determining that the ventricular activity metric meets the output criteria when the representative value is greater than a threshold atrioventricular activation time and the range is greater than a threshold range.

17 . The method of claim 11 further comprising determining the ventricular activity metric by determining a sum of differences between successive atrioventricular activation times of the determined atrioventricular activation times.

18 . The method of claim 11 further comprising determining the fiducial point of the motion signal as a maximum peak amplitude of the motion signal sensed during the respective atrial cycle.

19 . The method of claim 11 further comprising:

detecting a condition for monitoring for atrioventricular block; and

determining the ventricular activation times in response to detecting the condition for monitoring for atrioventricular block.

20 . The method of claim 11 further comprising:

sensing a cardiac electrical signal;

storing an episode of at least one of the cardiac electrical signal and the motion signal in response to determining that the ventricular event metric meets the atrioventricular block criteria; and

transmitting the stored episode.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2023
From: GALARNEAU, MICHELLE M.; GANION, VINCENT P.; GREENHUT, SAUL E.; GRINBERG, YANINA; SHELDON, TODD J.; SOLHEIM, PAUL R.; YOON, HYUN J.
To: MEDTRONIC, INC.
Reel/Frame 064004/0293 →
Continuity (3)
Continuation 17221404 · Apr 2, 2021
Provisional Application 63006208 · Apr 7, 2020
Related Publication 20230330420A1 · Oct 19, 2023
References Cited (40)
US 4485813A · Anderson et al. · 1984 [cited by applicant]
US 5052388A · Sivula et al. · 1991 [cited by applicant]
US 5507782A · Kieval et al. · 1996 [cited by applicant]
US 5593431A · Sheldon · 1997 [cited by applicant]
US 5720769A · van Oort et al. · 1998 [cited by applicant]
US 5885471A · Ruben et al. · 1999 [cited by applicant]
US 6044297A · Sheldon et al. · 2000 [cited by applicant]
US 6654637B2 · Rouw et al. · 2003 [cited by applicant]
US 8055339B2 · Seim · 2011 [cited by applicant]
US 8204593B2 · Sheldon et al. · 2012 [cited by applicant]
US 8532785B1 · Crutchfield et al. · 2013 [cited by applicant]
US 8731662B2 · Imran · 2014 [cited by applicant]
US 8761880B2 · Maskara et al. · 2014 [cited by applicant]
US 8788028B2 · Kumar et al. · 2014 [cited by applicant]
US 9592391B2 · Stahmann et al. · 2017 [cited by applicant]
US 9694186B2 · Carney et al. · 2017 [cited by applicant]
US 9724518B2 · Sheldon et al. · 2017 [cited by applicant]
US 9808633B2 · Bonner et al. · 2017 [cited by applicant]
US 10207116B2 · Sheldon et al. · 2019 [cited by applicant]
US 10463866B2 · Stahmann et al. · 2019 [cited by applicant]
US 11504536B2 · Drake et al. · 2022 [cited by applicant]
US 20070179541A1 · Prakash et al. · 2007 [cited by applicant]
US 20080234771A1 · Chinchoy et al. · 2008 [cited by applicant]
US 20100318150A1 · Graindorge · 2010 [cited by applicant]
US 20120095521A1 · Hintz · 2012 [cited by applicant]
US 20120215274A1 · Koh et al. · 2012 [cited by applicant]
US 20140121720A1 · Bonner et al. · 2014 [cited by applicant]
US 20160015984A1 · Demmer et al. · 2016 [cited by applicant]
US 20180085588A1 · Splett et al. · 2018 [cited by applicant]
US 20180085589A1 · Splett et al. · 2018 [cited by applicant]
US 20180117337A1 · Demmer et al. · 2018 [cited by applicant]
US 20180161580A1 · Demmer et al. · 2018 [cited by applicant]
US 20190029821A1 · Nguyen et al. · 2019 [cited by applicant]
US 20190083779A1 · Yang et al. · 2019 [cited by applicant]
US 20190321634A1 · Sheldon et al. · 2019 [cited by applicant]
EP 3260167A1 · 2017 [cited by applicant]
WO 2006086435A2 · 2006 [cited by applicant]
WO 2016171891A1 · 2016 [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/025846 mailed Jul. 12, 2021. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2021/025846 mailed Oct. 6, 2022. [cited by applicant]